SNDL completes acquisition of Surterra Holdings' assets, strengthening its U.S. medical cannabis footprint and positioning for Nasdaq‑consolidated operations
Executive summary: SNDL completed the acquisition of certain assets of Surterra Holdings (Parallel), a U.S. medical cannabis operator. The transaction expands SNDL’s U.S. medical cannabis scale, adds dispensary and cultivation assets, and positions the company for a Nasdaq‑consolidated U.S. medical cannabis operation.
Who is involved: SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), Surterra Holdings (Parallel), and Nasdaq as the intended listing venue.
Likely next: Integration of the acquired assets, potential SEC filing disclosing the deal, and evaluation of a Nasdaq uplisting or consolidation of U.S. medical cannabis operations.
SNDL Inc. announced on July 27, 2026 that it has finished purchasing selected assets from Surterra Holdings (operating as Parallel), a U.S. vertical cannabis operator. The deal adds medical‑cannabis dispensary and cultivation assets to SNDL’s portfolio and is intended to support a future Nasdaq‑listed, consolidated U.S. medical cannabis business. The announcement was issued via a press release and contains no forward‑looking guidance beyond the stated strategic intent.
Timeline
- — SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations (GlobeNewswire)